题名 | Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma |
作者 | Wang, Qian1; Xu, Chunwei2,3,4; Wang, Wenxian3; Zhang, Yongchang5; Li, Ziming6; Song, Zhengbo3; Wang, Jiandong7; Yu, Jinpu8; Liu, Jingjing9; Zhang, Shirong10; Cai, Xiuyu11; Li, Wen12; Zhan, Ping4; Liu, Hongbing4; Lv, Tangfeng4; Miao, Liyun13; Min, Lingfeng14; Li, Jiancheng15; Liu, Baogang16; Yuan, Jingping17; Jiang, Zhansheng18; Lin, Gen19; Chen, Xiaohui20; Pu, Xingxiang21; Rao, Chuangzhou22; Lv, Dongqing23
![]() |
发表日期 | 2023-09 |
发表期刊 | Thoracic cancer 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Journal Article |
关键词 | diagnosis malignant pleural mesothelioma prognosis treatment |
其他关键词 | MODULATED RADIATION-THERAPY ; PEMETREXED PLUS CARBOPLATIN ; MULTICENTER PHASE-II ; OPEN-LABEL ; EXTRAPLEURAL PNEUMONECTOMY ; HEMITHORACIC RADIATION ; 1ST-LINE CHEMOTHERAPY ; SURGICAL-MANAGEMENT ; DOUBLE-BLIND ; LUNG-CANCER |
摘要 | Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high-risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow-up. |
出版者 | WILEY |
ISSN | 1759-7706 |
EISSN | 1759-7714 |
卷号 | 14期号:26页码:2715-2731 |
DOI | 10.1111/1759-7714.15022 |
页数 | 17 |
WOS类目 | Oncology ; Respiratory System |
WOS研究方向 | Oncology ; Respiratory System |
WOS记录号 | WOS:001032219600001 |
收录类别 | PUBMED ; SCIE ; SCOPUS |
在线发表日期 | 2023-07 |
URL | 查看原文 |
PubMed ID | 37461124 |
SCOPUSEID | 2-s2.0-85165286682 |
通讯作者地址 | [Liu, Anwen]Department of Oncology,Second Affiliated Hospital of Nanchang University,Jiangxi,Nanchang,330006,China ; [Zhong, Wenzhao]Guangdong Lung Cancer Institute,Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,School of Medicine,Guangdong,Guangzhou,510080,China ; [Fang, Wenfeng]Department of Medical Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangdong,Guangzhou,510060,China |
Scopus学科分类 | Oncology;Pulmonary and Respiratory Medicine |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/181709 |
专题 | 其他_附属台州医院(浙江省台州医院) 其他_附属舟山医院(舟山医院) |
通讯作者 | Liu, Anwen; Zhong, Wenzhao; Fang, Wenfeng |
作者单位 | 1.Department of Respiratory Medicine,Affiliated Hospital of Nanjing University of Chinese Medicine,Jiangsu Province Hospital of Chinese Medicine,Nanjing,China; 2.Institute of Cancer and Basic Medicine (ICBM),Chinese Academy of Sciences,Hangzhou,China; 3.Department of Chemotherapy,Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital),Hangzhou,China; 4.Department of Respiratory Medicine,Affiliated Jinling Hospital,Medical School of Nanjing University,Nanjing,China; 5.Department of Medical Oncology,Lung Cancer and Gastrointestinal Unit,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,China; 6.Department of Shanghai Lung Cancer Center,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai,China; 7.Department of Pathology,Affiliated Jinling Hospital,Medical School of Nanjing University,Nanjing,China; 8.Department of Cancer Molecular Diagnostics Core,Tianjin Medical University Cancer Institute and Hospital,Tianjin,China; 9.Department of Thoracic Cancer,Jilin Cancer Hospital,Changchun,China; 10.Translational Medicine Research Center,Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,Affiliated Hangzhou First People's Hospital,Cancer Center,Zhejiang University School of Medicine,Hangzhou,China; 11.Department of VIP Inpatient,Sun Yet-Sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou,China; 12.Key Laboratory of Respiratory Disease of Zhejiang Province,Department of Respiratory and Critical Care Medicine,Second Affiliated Hospital of Zhejiang University School of Medicine,Cancer Center,Zhejiang University,Hangzhou,China; 13.Department of Respiratory Medicine,Affiliated Drum Tower Hospital,Medical School of Nanjing University,Nanjing,China; 14.Department of Respiratory Medicine,Clinical Medical School of Yangzhou University,Subei People's Hospital of Jiangsu Province,Yangzhou,China; 15.Department of Radiation Oncology,Fujian Medical University Cancer Hospital & Fujian Cancer Hospital,Fuzhou,China; 16.Department of Oncology,Harbin Medical University Cancer Hospital,Harbin,China; 17.Department of Pathology,Renmin Hospital of Wuhan University,Wuhan,China; 18.Department of Integrative Oncology,Tianjin Medical University Cancer Institute and Hospital,Tianjin,China; 19.Department of Medical Oncology,Fujian Medical University Cancer Hospital & Fujian Cancer Hospital,Fuzhou,China; 20.Department of Thoracic Surgery,Fujian Medical University Cancer Hospital & Fujian Cancer Hospital,Fuzhou,China; 21.Department of Medical Oncology,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,China; 22.Department of Radiotherapy and Chemotherapy,Hwamei Hospital,University of Chinese Academy of Sciences,Ningbo,China; 23.Department of Pulmonary Medicine,Taizhou Hospital of Wenzhou Medical University,Taizhou,China; 24.Department of Respiratory Medicine,the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital),Fujian Medical University,Fuzhou,China; 25.Department of Oncology,Beijing Tiantan Hospital,Capital Medical University,Beijing,China; 26.Department of Medical Oncology,Peking University International Hospital,Beijing,China; 27.State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University),Guangzhou,China; 28.Department of Thoracic Oncology,Shanxi Academy of Medical Sciences,Shanxi Bethune Hospital,Taiyuan,China; 29.Department of Medical Oncology,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,China; 30.Department of Oncology,Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China; 31.Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China; 32.Department of Oncology,the Third Xiangya Hospital,Central South University,Changsha,China; 33.Department of Medical Oncology,the First Affiliated Hospital of Medicine,Xiamen University,Xiamen,China; 34.Zhejiang Key Laboratory of Radiation Oncology,Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Hangzhou,China; 35.Department of Medical Oncology,Sichuan Cancer Hospital & Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology,Chengdu,China; 36.Department of Radiation Oncology,Fudan University Shanghai Cancer Center,Shanghai,China; 37.Department of Oncology,Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital,Nanjing,China; 38.Department of Cell Biology,College of Medicine,Jiaxing University,Jiaxing,China; 39.Department of Medical,Shanghai OrigiMed Co,Ltd,Shanghai,China; 40.Department of Oncology,Baotou Cancer Hospital,Baotou,China; 41.Department of Thoracic Disease Diagnosis and Treatment Center,Zhejiang Rongjun Hospital,The Third Affiliated Hospital of Jiaxing University,Jiaxing,China; 42.Department of Thoracic Surgery,Zhoushan Hospital,Wenzhou Medical University,Zhoushan,China; 43.Department of Oncology,Second Affiliated Hospital of Nanchang University,Nanchang,China; 44.Department of Pathology,Shanxi Academy of Medical Sciences,Shanxi Bethune Hospital,Taiyuan,China; 45.Department of Oncology,The First Affiliated Hospital of Anhui Medical University,Hefei,China; 46.Department of Interventional Oncology,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou,China; 47.Department of Respiratory Medicine,Huzhou Hospital,Zhejiang University School of Medicine,Huzhou,China; 48.Department of Oncology,Lishui Municipal Central Hospital,Lishui,China; 49.Department of Oncology,the Second Affiliated Hospital of Medical College,Xi'an Jiaotong University,Xi'an,China; 50.Department of Pathology,The Second Hospital of Jilin University,Changchun,China; 51.Senior Department of Oncology,The 5th Medical Center of PLA General Hospital,Beijing,China; 52.Department of Radiation Oncology,Affiliated Jinling Hospital,Medical School of Nanjing University,Nanjing,China; 53.Department of Respiratory Medicine,The Affiliated Jiangning Hospital of Nanjing Medical University,Nanjing,China; 54.Department of Clinical Oncology,The 901 Hospital of Joint Logistics Support Force of People Liberation Army,Hefei,China; 55.Department of Respiratory Medicine,Affiliated Hospital of Jiangxi University of Chinese Medicine,Jiangxi Province Hospital of Chinese Medicine,Nanchang,China; 56.Guangdong Lung Cancer Institute,Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,School of Medicine,Guangzhou,China; 57.Department of Respiratory Medicine,Zhongshan Hospital,Fudan University,Shanghai,China; 58.Department of Thoracic Surgery,Xuzhou Central Hospital,Xuzhou Clinical School of Xuzhou Medical University,Xuzhou,China; 59.Department of Oncology,The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou,China; 60.Department of Thoracic Surgery,The Fourth Hospital of Hebei Medical University,Shijiazhuang,China; 61.Department of Clinical Biobank,Affiliated Hospital of Nantong University,Nantong,China; 62.Department of Respiratory Medicine,Huashan Hospital,Fudan University,Shanghai,China; 63.Department of Pathology,Shaoxing People's Hospital (Shaoxing Hospital,Zhejiang University School of Medicine),Shaoxing,China; 64.Department of Oncology,The Second Affiliated Hospital of Guilin Medical University,Guilin,China; 65.International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE),Guangzhou City Key Laboratory of Precision Chemical Drug Development,School of Pharmacy,Jinan University,Guangzhou,China; 66.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital & Institute,Beijing,China; 67.Department of Pathology,The Fourth Hospital of Hebei Medical University,Shijiazhuang,China; 68.Department of Pathology,Fudan University Shanghai Cancer Center,Shanghai,China; 69.Department of Internal Medicine,The Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou,China; 70.Department of Pathology,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang,China; 71.Department of Medical Oncology,Jiangsu Cancer Hospital,Nanjing Medical University Affiliated Cancer Hospital,Nanjing,China; 72.Institute of Respiratory Diseases,Xinjian Hospital,Third Military Medical University,Chongqing,China; 73.Department of Medical Oncology,Sir Run Run Shaw Hospital,Zhejiang University,Hangzhou,China; 74.Department of Radiology,Lishui Municipal Central Hospital,Lishui,China; 75.Department of Thoracic Surgery,Affiliated Jinling Hospital,Medical School of Nanjing University,Nanjing,China; 76.Department of Oncology,Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,Affiliated Hangzhou Cancer Hospital,Cancer Center,Zhejiang University School of Medicine,Hangzhou,China; 77.Department of Clinical Pathology,The First Affiliated Hospital of Jinan University,Guangzhou,China; 78.Department of Medical Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou,China |
推荐引用方式 GB/T 7714 | Wang, Qian,Xu, Chunwei,Wang, Wenxian,et al. Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma[J]. Thoracic cancer,2023,14(26):2715-2731. |
APA | Wang, Qian., Xu, Chunwei., Wang, Wenxian., Zhang, Yongchang., Li, Ziming., ... & Fang, Wenfeng. (2023). Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thoracic cancer, 14(26), 2715-2731. |
MLA | Wang, Qian,et al."Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma".Thoracic cancer 14.26(2023):2715-2731. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论